InvestorsHub Logo
Followers 24
Posts 5031
Boards Moderated 0
Alias Born 09/27/2005

Re: gfp927z post# 15052

Tuesday, 10/22/2019 6:13:50 AM

Tuesday, October 22, 2019 6:13:50 AM

Post# of 19856
As of June 29, 2019, Baker Bros. owned approx. 2.24% of the outstanding shares of AXSM -

https://finance.yahoo.com/quote/AXSM/holders?p=AXSM

>>>Baker Brothers Advisors, LLC 772,286 Jun 29, 201 2.24% $19,886,364<<<

Thanks for your previous post on FOMX. I hadn't been aware that >>>Foamix Pharmaceuticals Ltd. has development and license agreements with Bayer HealthCare AG; LEO Pharma A/S; Mylan N.V.; and Actavis plc.<<<

I think it's too bad that you're adamant about not buying individual stocks like AXSM and FOMX because of your disastrous experience with Cortex, PolyMedix, etc. Both of us should have known that biotechs in the very early stages of development have low probabilities of success. However, FOMX has crossed the goal line and AXSM is close to it. Both could be moonshots.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.